# H1N1sw Vaccine in Adult Transplant Recipients

> **NCT01069601** · PHASE2 · TERMINATED · sponsor: **HepNet Study House, German Liverfoundation** · enrollment: 13 (actual)

## Conditions studied

- Immunocompromised

## Interventions

- **BIOLOGICAL:** Focetria (2x H1N1 vaccine with MF59 adjuvants)

## Key facts

- **NCT ID:** NCT01069601
- **Lead sponsor:** HepNet Study House, German Liverfoundation
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02
- **Primary completion:** 2011-04
- **Final completion:** 2012-04
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** End of H1N1 Swine Flu Pandemic
- **Last updated:** 2012-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01069601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01069601, "H1N1sw Vaccine in Adult Transplant Recipients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01069601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*